Loading...
Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma
We synthesized a novel aryl-guanidino compound, DCZ3301, and found that it has potent cytotoxicity against multiple human cancer cell lines. The anticancer activity was most potent against multiple myeloma (MM). DCZ3301 induced cytotoxicity in MM cell lines, as well as patient myeloma cells, in part...
Na minha lista:
| Udgivet i: | Theranostics |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ivyspring International Publisher
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5667341/ https://ncbi.nlm.nih.gov/pubmed/29109769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.18345 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|